Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,840 | 7,430 | 7,420 | 7,450 | 7,380 |
| Receivables | 970 | 0 | 0 | 0 | 1 |
| Other current assets | 190 | 0 | 0 | 0 | -1 |
| TOTAL | $4,000 | $7,430 | $7,420 | $7,450 | $7,380 |
| Non-Current Assets | |||||
| PPE Net | 4,740 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 230 | 40 | 40 | 8 | 9 |
| TOTAL | $4,970 | $40 | $40 | $8 | $9 |
| Total Assets | $5,080 | $7,470 | $7,460 | $7,460 | $7,390 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 670 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 0 | 30 | 30 | 0 | 0 |
| Other current liabilities | 20 | 0 | 0 | 0 | 0 |
| TOTAL | $1,070 | $70 | $80 | $70 | $50 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 50 | 7,400 | 7,370 | 7,380 | 7,330 |
| TOTAL | $50 | $7,400 | $7,370 | $7,380 | $7,330 |
| Total Liabilities | $1,120 | $7,470 | $7,460 | $7,460 | $7,390 |
| Shareholders' Equity | |||||
| Common Shares | 1 | 0 | 0 | 0 | 0 |
| Retained earnings | -950 | 0 | 0 | 0 | 0 |
| Other shareholders' equity | -491 | 0 | 0 | 0 | 0 |
| TOTAL | $3,950 | $0 | $0 | $0 | $0 |
| Total Liabilities And Equity | $5,070 | $7,470 | $7,460 | $7,460 | $7,390 |